VanEck Associates’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325M | Buy |
1,486,187
+38,339
| +3% | +$8.39M | 0.37% | 59 |
|
|
2025
Q1 | $324M | Buy |
1,447,848
+758,355
| +110% | +$170M | 0.42% | 61 |
|
|
2024
Q4 | $226M | Buy |
689,493
+676,167
| +5,074% | +$221M | 0.29% | 86 |
|
|
2024
Q3 | $3.82M | Sell |
13,326
-722
| -5% | -$207K | ﹤0.01% | 742 |
|
|
2024
Q2 | $4.63M | Buy |
14,048
+436
| +3% | +$144K | 0.01% | 608 |
|
|
2024
Q1 | $5.39M | Buy |
13,612
+2,873
| +27% | +$1.14M | 0.01% | 557 |
|
|
2023
Q4 | $3.78M | Buy |
10,739
+226
| +2% | +$79.6K | 0.01% | 625 |
|
|
2023
Q3 | $3.95M | Sell |
10,513
-2,405
| -19% | -$902K | 0.01% | 565 |
|
|
2023
Q2 | $4.94M | Sell |
12,918
-221
| -2% | -$84.5K | 0.01% | 517 |
|
|
2023
Q1 | $4.55M | Buy |
13,139
+330
| +3% | +$114K | 0.01% | 507 |
|
|
2022
Q4 | $3.02M | Sell |
12,809
-237
| -2% | -$55.8K | 0.01% | 584 |
|
|
2022
Q3 | $3.21M | Buy |
13,046
+950
| +8% | +$234K | 0.01% | 546 |
|
|
2022
Q2 | $3.66M | Sell |
12,096
-144
| -1% | -$43.5K | 0.01% | 529 |
|
|
2022
Q1 | $5.03M | Buy |
12,240
+1,360
| +13% | +$559K | 0.01% | 505 |
|
|
2021
Q4 | $5.1M | Buy |
10,880
+1,384
| +15% | +$649K | 0.01% | 506 |
|
|
2021
Q3 | $4.03M | Buy |
9,496
+417
| +5% | +$177K | 0.01% | 511 |
|
|
2021
Q2 | $3.26M | Buy |
9,079
+1,213
| +15% | +$436K | 0.01% | 547 |
|
|
2021
Q1 | $2.22M | Buy |
7,866
+882
| +13% | +$248K | 0.01% | 593 |
|
|
2020
Q4 | $1.98M | Buy |
6,984
+2,103
| +43% | +$596K | 0.01% | 546 |
|
|
2020
Q3 | $1.34M | Buy |
4,881
+1,138
| +30% | +$313K | ﹤0.01% | 575 |
|
|
2020
Q2 | $850K | Buy |
+3,743
| New | +$850K | ﹤0.01% | 648 |
|